Cartalax
A 3-amino-acid Khavinson “bioregulator” (Ala-Glu-Asp) said to support cartilage and connective tissue.
Not approved for human use; sold as a research chemical.
Used for
- Joint and cartilage wear
- Connective tissue and skin aging
How it works
Like the other Khavinson peptides, it is claimed to enter cells and adjust gene expression in the tissue it was named for. The evidence is cell-culture work from the same group.
What the research shows
- In aging human skin fibroblasts grown in the lab, AED changed markers of cell aging and collagen activity.
- In aging stem-cell cultures, short peptides including AED shifted the expression of aging-related genes.
- No controlled human trials; nearly all work comes from the St Petersburg group that developed it.
Dosing
Dosing isn’t listed on the public site. In the app, each published option is shown with its source (a drug label, a clinical guideline, a trial or community reports) and can be turned into a protocol you review.
Work out the units to draw for your vial →Side effects
- Few reported
Cautions
- Evidence is lab work from one group: expect less than the marketing says.
- Research-chemical vials have no quality control: purity, dose and sterility vary. Third-party testing helps but is no guarantee.
Storage
Unmixed powder: freezer or fridge, away from light.
Once mixed with bacteriostatic water: fridge; the common rule is to use it within 28 days.
There is no label or published stability data for this one, so treat these as habits, not limits.
More in Healing & recovery
Reference only, not medical advice. Written for this app from the cited research. Doses marked community-reported are not from trials.